Vivo Infusion Acquires Infusion Associates from Boyne Capital

July 9, 2024

Vivo Infusion, a national provider of community-based ambulatory infusion and injection services, has acquired Infusion Associates, a Midwest-focused ambulatory infusion operator headquartered in Grand Rapids, Michigan. The deal—sold by Boyne Capital and supported by Vivo's investor InTandem Capital Partners—adds Infusion Associates' 14 locations in Michigan, Minnesota, Ohio and Wisconsin to the Vivo platform as it nears management of ~80 centers across 15 states; financial terms were not disclosed.

Buyers
Vivo Infusion, InTandem Capital Partners
Targets
Infusion Associates
Sellers
Boyne Capital
Platforms
Vivo Infusion
Location
Michigan, United States
Transaction Type
Addon

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.